Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.
Published May 11, 2022 · Recall initiated: April 1, 2022
Summary
FDA records medical device Class II recall Z-1019-2022, published May 11, 2022 and initiated April 1, 2022. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 300 devices; Lot: Product Code: FT12150; Lot: SP21J21-1584173. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential for foreign matter.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Distribution in the United States including AL, CA, KY, NY, OR, PA, and TX OUS distribution to Japan, Italy, Netherlands, Switzerland, and United Kingdom
- Lot
- Product Code: FT12150; Lot: SP21J21-1584173
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATruSystem 7500 surgical table, Model/Catalog Number: 4091000November 11, 2026
- FDATruSystem 7000 U Operating Table (dV), Product Code 1723633November 11, 2026
- FDATruSystem 7500 Hybrid Plus (FC), Fixed-Installation Operating Table Column, Model/Catalog Number: 1854087November 11, 2026
- FDAOperating Table TruSystem 7000 U, Surgical table, universal, Model/Catalog Number: 1604788November 11, 2026
- FDAOlive; TOP SAVOR Licorice Flavored Olive; Net wt: 500g (17.63oz); Ingredients: olive, sugar, salt, licoriceMay 11, 2022
- FDAADVIA Centaur Enhanced Estradiol (eE2) 500T - In vitro diagnostic use in the quantitative determination ofMay 11, 2022
Questions about this recall
Was Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis. recalled?
Yes. FDA published recall Z-1019-2022 on May 11, 2022. Reported hazard: There is a potential for foreign matter.
What should I do if I have this product?
Voluntary: Firm initiated · Letter